These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 24674157

  • 1. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA, Frohnauer J, Merkelbach-Bruse S, Schildhaus HU, Dimmler A, Schubert T, Boltze C, König H, Fuchs F, Sirbu H, Rieker RJ, Agaimy A, Hartmann A, Haller F.
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [Abstract] [Full Text] [Related]

  • 2. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N, Bandoh S, Ishii T, Tadokoro A, Watanabe N, Takahama T, Haba R, Imataki O, Dobashi H, Matsunaga T.
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [Abstract] [Full Text] [Related]

  • 3. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ.
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [Abstract] [Full Text] [Related]

  • 4. TaqMan based real time PCR assay targeting EML4-ALK fusion transcripts in NSCLC.
    Robesova B, Bajerova M, Liskova K, Skrickova J, Tomiskova M, Pospisilova S, Mayer J, Dvorakova D.
    Lung Cancer; 2014 Jul; 85(1):25-30. PubMed ID: 24792336
    [Abstract] [Full Text] [Related]

  • 5. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

  • 6. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z.
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [Abstract] [Full Text] [Related]

  • 7. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K, Choi YL, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Takada S, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H.
    Clin Cancer Res; 2008 Oct 15; 14(20):6618-24. PubMed ID: 18927303
    [Abstract] [Full Text] [Related]

  • 8. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
    Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M.
    Cancer Genet; 2011 Jan 15; 204(1):45-52. PubMed ID: 21356191
    [Abstract] [Full Text] [Related]

  • 9. A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer.
    Sakai K, Okamoto I, Takezawa K, Hirashima T, Kaneda H, Takeda M, Matsumoto K, Kimura H, Fujita Y, Nakagawa K, Arao T, Nishio K.
    J Thorac Oncol; 2012 May 15; 7(5):913-8. PubMed ID: 22722791
    [Abstract] [Full Text] [Related]

  • 10. A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer.
    Soda M, Isobe K, Inoue A, Maemondo M, Oizumi S, Fujita Y, Gemma A, Yamashita Y, Ueno T, Takeuchi K, Choi YL, Miyazawa H, Tanaka T, Hagiwara K, Mano H, North-East Japan Study Group, ALK Lung Cancer Study Group.
    Clin Cancer Res; 2012 Oct 15; 18(20):5682-9. PubMed ID: 22908099
    [Abstract] [Full Text] [Related]

  • 11. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
    Vollbrecht C, Lenze D, Hummel M, Lehmann A, Moebs M, Frost N, Jurmeister P, Schweizer L, Kellner U, Dietel M, von Laffert M.
    BMC Cancer; 2018 Nov 22; 18(1):1158. PubMed ID: 30466405
    [Abstract] [Full Text] [Related]

  • 12. The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer.
    Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, Cohen C.
    Appl Immunohistochem Mol Morphol; 2015 Apr 22; 23(4):239-44. PubMed ID: 25265433
    [Abstract] [Full Text] [Related]

  • 13. Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay.
    Rho JK, Lee H, Park CS, Choi CM, Lee JC.
    Clin Chem Lab Med; 2013 Sep 22; 51(9):1843-8. PubMed ID: 23612660
    [Abstract] [Full Text] [Related]

  • 14. Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan.
    Wu YC, Chang IC, Wang CL, Chen TD, Chen YT, Liu HP, Chu Y, Chiu YT, Wu TH, Chou LH, Chen YR, Huang SF.
    PLoS One; 2013 Sep 22; 8(8):e70839. PubMed ID: 23951022
    [Abstract] [Full Text] [Related]

  • 15. ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.
    McLeer-Florin A, Duruisseaux M, Pinsolle J, Dubourd S, Mondet J, Phillips Houlbracq M, Magnat N, Fauré J, Chatagnon A, de Fraipont F, Giaj Levra M, Toffart AC, Ferretti G, Hainaut P, Brambilla E, Moro-Sibilot D, Lantuejoul S.
    Lung Cancer; 2018 Feb 22; 116():15-24. PubMed ID: 29413046
    [Abstract] [Full Text] [Related]

  • 16. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    Inamura K, Takeuchi K, Togashi Y, Nomura K, Ninomiya H, Okui M, Satoh Y, Okumura S, Nakagawa K, Soda M, Choi YL, Niki T, Mano H, Ishikawa Y.
    J Thorac Oncol; 2008 Jan 22; 3(1):13-7. PubMed ID: 18166835
    [Abstract] [Full Text] [Related]

  • 17. Detection of Echinoderm Microtubule Associated Protein Like 4-Anaplastic Lymphoma Kinase Fusion Genes in Non-small Cell Lung Cancer Clinical Samples by a Real-time Quantitative Reverse Transcription Polymerase Chain Reaction Method.
    Zhao J, Zhao JY, Chen ZX, Zhong W, Li LY, Liu LC, Hu XX, Chen WJ, Wang MZ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec 20; 38(6):643-649. PubMed ID: 28065229
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T, Sonobe M, Kobayashi M, Yoshizawa A, Menju T, Nakayama E, Mino N, Iwakiri S, Sato K, Miyahara R, Okubo K, Manabe T, Date H.
    Ann Surg Oncol; 2010 Mar 20; 17(3):889-97. PubMed ID: 20183914
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset.
    Guo Y, Ma J, Lyu X, Liu H, Wei B, Zhao J, Fu S, Ding L, Zhang J.
    BMC Cancer; 2014 Nov 18; 14():834. PubMed ID: 25407901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.